Literature DB >> 22592532

Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation.

Marcella Salzano1, Maria Rosaria Rusciano, Eleonora Russo, Maurizio Bifulco, Loredana Postiglione, Mario Vitale.   

Abstract

The calcium/calmodulin-dependent kinase II (CaMKII) participates with Ras to Raf-1 activation, and it is necessary for activation of the extracellular signal-regulated kinase (ERK) by different factors in epithelial and mesenchimal cells. Raf-1 activation is a complex multistep process, and its maximal activation is achieved by phosphorylation at Y341 by Src and at S338 by other kinase/s. Although early data proposed the involvement of p21-activated kinase 3 (Pak3), the kinase phosphorylating S338 remains to be definitively identified. In this study, we verified the hypothesis that CaMKII phosphorylates Raf-1 at Ser338. To do so, we determined the role of CaMKII in Raf-1 and ERK activation by oncogenic Ras and other factors. Serum, fibronectin, Src (Y527) and Ras (V12) activated CaMKII and ERK, at different extents. The inhibition of CaMKII attenuated Raf-1 and ERK activation by all these factors. CaMKII was also necessary for the phosphorylation of Raf-1 at S338 by serum, fibronectin and Ras. Conversely, inhibition of Pak3 activation by blocking phosphatidylinositol 3-kinase was ineffective. The direct phosphorylation of S338 Raf-1 by CaMKII was demonstrated in vitro by interaction of purified kinases. These results demonstrate that Ras activates CaMKII, which, in turn, phosphorylates Raf-1 at S338 and participates in ERK activation upon different stimuli.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592532     DOI: 10.4161/cc.20543

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

2.  The road to ERK activation: Do neurons take alternate routes?

Authors:  Nadiatou Miningou; Kim T Blackwell
Journal:  Cell Signal       Date:  2020-01-13       Impact factor: 4.315

3.  Activation of RAF1 (c-RAF) by the Marine Alkaloid Lasonolide A Induces Rapid Premature Chromosome Condensation.

Authors:  Rozenn Jossé; Yong-Wei Zhang; Valentin Giroux; Arun K Ghosh; Ji Luo; Yves Pommier
Journal:  Mar Drugs       Date:  2015-06-05       Impact factor: 5.118

4.  Ca(2+) permeation and/or binding to CaV1.1 fine-tunes skeletal muscle Ca(2+) signaling to sustain muscle function.

Authors:  Chang Seok Lee; Adan Dagnino-Acosta; Viktor Yarotskyy; Amy Hanna; Alla Lyfenko; Mark Knoblauch; Dimitra K Georgiou; Ross A Poché; Michael W Swank; Cheng Long; Iskander I Ismailov; Johanna Lanner; Ted Tran; KeKe Dong; George G Rodney; Mary E Dickinson; Christine Beeton; Pumin Zhang; Robert T Dirksen; Susan L Hamilton
Journal:  Skelet Muscle       Date:  2015-01-29       Impact factor: 4.912

5.  Stochastic Induction of Long-Term Potentiation and Long-Term Depression.

Authors:  G Antunes; A C Roque; F M Simoes-de-Souza
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

6.  A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1.

Authors:  Sung Wook Park; Jennifer Nhieu; Shawna D Persaud; Michelle C Miller; Youlin Xia; Yi-Wei Lin; Yu-Lung Lin; Hiroyuki Kagechika; Kevin H Mayo; Li-Na Wei
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

Review 7.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

8.  Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration.

Authors:  Masanari Umemura; Erdene Baljinnyam; Stefan Feske; Mariana S De Lorenzo; Lai-Hua Xie; Xianfeng Feng; Kayoko Oda; Ayako Makino; Takayuki Fujita; Utako Yokoyama; Mizuka Iwatsubo; Suzie Chen; James S Goydos; Yoshihiro Ishikawa; Kousaku Iwatsubo
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

9.  The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.

Authors:  Tao Wang; Zhuo Liu; Shuiming Guo; Licheng Wu; Mingchao Li; Jun Yang; Ruibao Chen; Hua Xu; Shaoxin Cai; Hui Chen; Weiyong Li; Liang Wang; Zhiquan Hu; Qianyuan Zhuang; Shaohua Xu; Liping Wang; Jihong Liu; Zhangqun Ye; Jun-Yuan Ji; Chenguang Wang; Ke Chen
Journal:  Oncotarget       Date:  2014-06-15

Review 10.  Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.

Authors:  Ufuk Degirmenci; Mei Wang; Jiancheng Hu
Journal:  Cells       Date:  2020-01-13       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.